Actively Recruiting

Phase 2
Age: 18Years - 85Years
MALE
ID05249634

Effect of JATENZO Therapy on Testosterone and Hemoglobin Levels in Men with Low Testosterone and Chronic Kidney Disease

Led by St. Louis University · Updated on 2026-04-30

20

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

Sponsors

S

St. Louis University

Lead Sponsor

C

Clarus Therapeutics, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying men with low testosterone and chronic kidney disease to evaluate the effects of an oral testosterone medication called JATENZO. The study aims to see if JATENZO can increase testosterone levels and improve hemoglobin (red blood cells), as well as muscle strength, lean mass, and sexual function. This is a Phase 2 clinical trial focused on men with hypogonadism and kidney issues. Participants will take the JATENZO pill daily for six months. Every 2 to 4 weeks, they will visit the study site for assessments. During these visits, blood samples will be collected, physical exams will be done, vital signs such as height, weight, and blood pressure will be measured, and questionnaires will be completed. Body composition will be measured by a scan, muscle strength will be tested, and the dose of JATENZO may be adjusted based on testosterone levels. Throughout the study, participants will be closely monitored with regular visits to track hormone levels, hemoglobin, muscle strength, lean mass, and sexual function. The main outcome measured is testosterone concentration after six months. Safety and health will be checked with blood tests and physical exams to ensure participant well-being during the trial, which may last up to six months of treatment plus follow-up.

CONDITIONS

Brief Title

Testosterone Treatment in Men With Chronic Kidney Disease

Who Can Participate

Age: 18Years - 85Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Men aged 18 to 85 years
  • Chronic kidney disease with eGFR between 15 and 45 ml/min/1.73m2
  • Low total serum testosterone levels below 300 ng/dl on two morning tests
  • Symptoms of low testosterone such as low libido, erectile dysfunction, fatigue, irritability, or decreased muscle mass
  • Normal iron stores with serum ferritin of at least 100 ng/mL and transferrin saturation of at least 20%
Not Eligible

You will not qualify if you...

  • Use of testosterone replacement therapy or androgen supplements in the past 6 months
  • Hematocrit over 48%
  • Treatment with erythropoiesis stimulating agents
  • Uncontrolled blood pressure over 180/100 mm Hg
  • Heart failure class III or IV
  • Recent (within 3 months) heart attack, stroke, or heart surgery
  • Breast cancer or history of prostate cancer
  • Prostate specific antigen over 4 ng/ml unless prostate cancer is ruled out
  • HIV infection or untreated hepatitis C
  • Untreated severe obstructive sleep apnea
  • Started iron replacement therapy in the last 3 months
  • Recent or recurrent deep vein thrombosis or pulmonary embolism
  • Use of warfarin
  • Planning to have children within the next year

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 6 months

Participants take the JATENZO pill daily to help increase testosterone levels and possibly improve hemoglobin, muscle strength, lean mass, and sexual function.

Visits every 2 to 4 weeks (in-person) for blood samples, physical exams, vital signs, questionnaires, body scans, and muscle strength tests. Dose may be adjusted based on testosterone levels.

Trial Site Locations

Total: 1 location

1

Saint Louis Univeristy

St Louis, Missouri, United States, 63104

Actively Recruiting

Loading map...

Research Team

S

Sandeep Dhindsa, MD

J

Jennifer Newman, RN

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Open-Label, Multiple-Dose, 52-Week Study and 24-Month Long-T...

Hypogonadism, Male

Actively Recruiting

20 locations

A High Protein Egg White Pudding for People With Kidney Fail...

Kidney Failure

Actively Recruiting

2 locations

Adia Med of Winter Park LLC Chronic Kidney Disease Research ...

Chronic Kidney Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here